Unichem Laboratories is currently trading at Rs. 586.20, up by 13.35 points or 2.33% from its previous closing of Rs. 572.85 on the BSE.
The scrip opened at Rs. 588.50 and has touched a high and low of Rs. 595.90 and Rs. 575.15 respectively. So far 8455 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 631.05 on 08-Aug-2024 and a 52 week low of Rs. 394.85 on 13-Sep-2023.
Last one week high and low of the scrip stood at Rs. 605.00 and Rs. 562.50 respectively. The current market cap of the company is Rs. 4139.51 crore.
The promoters holding in the company stood at 70.22%, while Institutions and Non-Institutions held 12.47% and 17.30% respectively.
Unichem Laboratories has received Voluntary Action Indicated (VAI) classification for its Goa formulation facility situated at Pilerne, Bardez from United States Food and Drug Administration (USFDA).
Earlier, USFDA had conducted an inspection at Unichem Laboratories’ Goa formulation facility from July 08, 2024 to July 15, 2024. The inspection closed with five observations which were more of procedural changes with none of these related to data integrity.
Unichem Laboratories is an international, integrated, specialty pharmaceutical company.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |